All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @abbott_collin on Instagram · 37s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @abbott_collin's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00For a BPC-157, where should you inject for a rotator cuff injury?
  2. 0:04So, everything around here where your dealt caps is fine, just obviously make sure not
  3. 0:09to jab yourself right there because that is a bone and that would hurt.
  4. 0:12Now, as far as poking yourself, because I'm going to get questions about this, if you
  5. 0:15are leaner you can get away with something like a 1564s.
  6. 0:20And if you are a little fluffier you might want to consider something like a 516.
  7. 0:26So, hope that helps.
  8. 0:28Hope you guys found this video informative.
  9. 0:30I'll have a source list and discount code to blow as to where you can get BPC-157.
  10. 0:35Be safe guys.
  11. 0:36Till next one, I'm out.

@abbott_collin's BPC-157 promotion lacks key safety info

Collin Abbott

Instagram creator

11.2K viewsView on Instagram

Quick answer

BPC-157 is a synthetic pentadecapeptide with demonstrated tendon and ligament healing effects in animal models, primarily through proposed modulation of growth hormone receptor expression and nitric oxide signaling. No peer-reviewed randomized controlled trials in humans have been published to date, and the compound holds no FDA approval for any human indication. The injection site guidance offered in this video, specifically targeting the periarticular deltoid region for rotator cuff pathology, has no clinical protocol basis in published human literature.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksBPC-157Provider discussion

Evidence signal

Source-backed review

Regulatory reality

BPC-157 access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @abbott_collin's BPC-157 promotion lacks key safety info, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

BPC-157 is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this bpc-157 video claims cluster

Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@abbott_collin's BPC-157 promotion lacks key safety info" from Collin Abbott. We read the clip as a Peptide social video fact-checks claim about BPC-157, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: BPC-157 is a synthetic pentadecapeptide with demonstrated tendon and ligament healing effects in animal models, primarily through proposed modulation of growth hormone receptor expression and nitric oxide signaling.

The reason this review is not generic is the source wording and the canonical claim label "peptides modernaminos international code abbott save 10 swissche." In this clip, the useful excerpt is: "For a BPC-157, where should you inject for a rotator cuff injury?" That wording changes the review because it points to BPC-157 safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. BPC-157 still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

All positive tendon healing data for BPC-157 comes from rat and rodent models, primarily from Sikiric et al.
People who land here are usually comparing the BPC-157 claim with bpc157, peptides, and healingpeptides.
The strongest next step is to compare the claim with FormBlends' BPC-157 guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

BPC-157 is a synthetic pentadecapeptide with demonstrated tendon and ligament healing effects in animal models, primarily through proposed modulation of growth hormone receptor expression and nitric oxide signaling.

FormBlends verdict

BPC-157 safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • BPC-157 is a synthetic pentadecapeptide with demonstrated tendon and ligament healing effects in animal models, primarily through proposed modulation of growth hormone receptor expression and nitric oxide signaling. No peer-reviewed randomized controlled trials in humans have been published to date, and the compound holds no FDA approval for any human indication. The injection site guidance offered in this video, specifically targeting the periarticular deltoid region for rotator cuff pathology, has no clinical protocol basis in published human literature.
  • Zero published randomized controlled trials in humans have evaluated BPC-157 for rotator cuff or any other musculoskeletal injury as of 2024.
  • All positive tendon healing data for BPC-157 comes from rat and rodent models, primarily from Sikiric et al. across studies in Current Pharmaceutical Design (2018) and Journal of Physiology - Paris (2000).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • BPC-157 decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.

Review BPC-157

What You'll Learn

  • Zero published randomized controlled trials in humans have evaluated BPC-157 for rotator cuff or any other musculoskeletal injury as of 2024.
  • All positive tendon healing data for BPC-157 comes from rat and rodent models, primarily from Sikiric et al. across studies in Current Pharmaceutical Design (2018) and Journal of Physiology - Paris (2000).
  • The FDA has not approved BPC-157 for any human use, and it is classified as a research chemical with no standardized dosing or manufacturing oversight.
  • The rationale for needle length varying by body composition has legitimate support in insulin injection literature, but this evidence does not transfer directly to BPC-157 subcutaneous protocols.
  • There is no published pharmacokinetic evidence that injecting BPC-157 near the injured shoulder produces higher local tissue concentrations than injecting at a distant subcutaneous site.
  • The creator earns affiliate commissions from the suppliers he recommends, which is a direct financial conflict of interest when evaluating his injection guidance.
  • Evidence-based treatments for rotator cuff injuries include supervised physical therapy, corticosteroid or platelet-rich plasma injections under imaging guidance, and surgical repair, all of which have human clinical trial data supporting their use.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @abbott_collin actually say?

The creator recommended injecting BPC-157 "around the deltoid caps" for a rotator cuff injury, specifically warning viewers not to inject directly into bone. He also gave needle gauge and length suggestions based on body composition, recommending a 1/2-inch needle for leaner individuals and a 5/16-inch for those with more subcutaneous fat.

To be fair, he kept the video short, didn't make wild therapeutic claims, and reminded people to "be safe." That restraint is worth noting. But the advice is still coming from someone selling affiliate codes to unregulated peptide suppliers, which matters when you're talking about injection protocols for a compound that has never been approved by the FDA for human use.

Does the science back this up?

The idea of injecting near the site of injury has some theoretical basis, but the human evidence is thin at best. Most of what we know about BPC-157 comes from animal studies, and the translation to humans is far from settled.

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. Rodent studies, including work by Sikiric et al. published repeatedly in journals like Current Pharmaceutical Design (2018) and Journal of Physiology - Paris (2000), have shown accelerated tendon and ligament healing in rat models. The mechanism appears to involve upregulation of growth hormone receptors and nitric oxide pathways. However, no randomized controlled trials in humans have been published as of this writing. Zero. The leap from rat tendon to human rotator cuff is a large one, and the creator doesn't acknowledge that gap at all.

  • Sikiric et al. (2018, Current Pharmaceutical Design): tendon healing in rats, not humans
  • No FDA-approved human indication exists for BPC-157
  • Subcutaneous injection protocols for peptides are generally adapted from insulin or growth hormone literature, not BPC-157 specific data

What did they get wrong (or right)?

The needle size logic is partially reasonable. Subcutaneous injections in insulin delivery literature do generally recommend shorter needles for leaner individuals and longer ones for those with more adipose tissue. A 2016 study by Hirsch et al. in Diabetes Technology & Therapeutics supports individualized needle length based on skin fold thickness. So the underlying principle isn't wrong.

What is wrong, or at least incomplete, is the framing that injecting near the deltoid is the right approach for a rotator cuff injury specifically. The rotator cuff involves four muscles and their tendons sitting deep to the deltoid. Subcutaneous injection near the shoulder doesn't mean the peptide is going to localize to the supraspinatus or infraspinatus. There is no good evidence that subcutaneous injection near an injury site produces meaningfully higher local concentrations than injecting elsewhere. The "inject near the injury" logic is biologically plausible but unproven for this compound in this context.

He also refers to needle sizes in a way that's easy to misread. "1564" and "516" appear to be shorthand for gauge and length combinations, but the transcript makes them nearly impossible to parse clearly. That ambiguity in an injection tutorial is a problem.

What should you actually know?

BPC-157 is not approved for human use in the United States, Canada, Australia, or the EU. It is sold as a "research chemical" by vendors like the ones this creator is affiliated with, which means no standardized dosing, no verified purity, and no regulatory oversight. The FDA has issued warnings about peptides sold through compounding pharmacies and research chemical suppliers.

If you have a rotator cuff injury, there are actual evidence-based options: physical therapy, corticosteroid injections under imaging guidance, and in some cases surgery. Those aren't exciting content, but they have human trial data behind them.

The creator isn't necessarily acting in bad faith, but he is giving injection guidance for an unapproved compound while earning affiliate commissions from the suppliers. That conflict of interest should be front of mind when you're deciding how much weight to give this advice. Watching a 30-second reel is not a substitute for a conversation with a sports medicine physician or orthopedic specialist who can actually assess your shoulder.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Collin Abbott · Instagram creator

11.2K views on this video

@modernaminos.international code “Abbott” save 10% Swisschems.is code “Abbott” save 10% Peptidepro.io code “Abbott” save 20% #bpc157 #peptides #healingpeptides #reels #explore #biohacking

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about zero published randomized controlled trials in humans have evaluated bpc-157?

Zero published randomized controlled trials in humans have evaluated BPC-157 for rotator cuff or any other musculoskeletal injury as of 2024.

What does the video say about all positive tendon healing data for bpc-157 comes from rat?

All positive tendon healing data for BPC-157 comes from rat and rodent models, primarily from Sikiric et al. across studies in Current Pharmaceutical Design (2018) and Journal of Physiology - Paris (2000).

What does the video say about the fda has not approved bpc-157 for any human use,?

The FDA has not approved BPC-157 for any human use, and it is classified as a research chemical with no standardized dosing or manufacturing oversight.

What does the video say about the rationale for needle length varying by body composition has?

The rationale for needle length varying by body composition has legitimate support in insulin injection literature, but this evidence does not transfer directly to BPC-157 subcutaneous protocols.

What does the video say about there?

There is no published pharmacokinetic evidence that injecting BPC-157 near the injured shoulder produces higher local tissue concentrations than injecting at a distant subcutaneous site.

What does the video say about the creator earns affiliate commissions from the suppliers he recommends,?

The creator earns affiliate commissions from the suppliers he recommends, which is a direct financial conflict of interest when evaluating his injection guidance.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Collin Abbott, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.